Evidence map›Paper›PMID 36594042›Full record

ArticleHeliyon2023

Main modulators of COVID-19 epidemic in sub-Saharan Africa.

Boris-Enock Zinsou, Diane Letourneur, Joël Siko, Raïssa Muriel de Souza, Frejus Adjagba, Pascal Pineau

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Boris-Enock ZinsouClinical Research Institute of Benin (IRCB), Atlantique, 04 BP: 1114 Abomey Calavi, Benin.
Diane LetourneurInstitut Pasteur, Université Paris Cité, CNRS UMR 6047, INSERM ERL1306, Unité "Toxines Bactériennes", F-75015 Paris, France.
Joël SikoClinical Research Institute of Benin (IRCB), Atlantique, 04 BP: 1114 Abomey Calavi, Benin.
Raïssa Muriel de SouzaCentre d'Excellence Africain en Innovations Biotechnologique pour l'Elimination des Maladies à Transmission Vectorielle (CEA/ITECH-MTV), Université Nazi Boni, Burkina Faso.
Frejus AdjagbaUniversity of Abomey Calavi, Benin.
Pascal PineauUnité « Organisation nucléaire et oncogenèse », INSERM U993, Institut Pasteur, 28 Rue du Docteur Roux, 75015 Paris, France.
Centre National de la Recherche Scientifique · FRInserm · FRNazi Boni University · BFUniversité d'Abomey-Calavi · BJ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic is responsible for an important global death toll from which sub-Saharan Africa (SSA) seems mostly protected. The reasons explaining this situation are still poorly understood. Methods: We analyzed the correlation between reported COVID-19 data between February 14, 2020 and May 18, 2021, and demographic, socioeconomic, climatic, diagnostic data, and comorbidities in 47 SSA countries. Different databases including the WHO data center, Our World in Data, and the World Bank were used. Findings: As of May 17, 2021, SSA reported 2% of COVID-19 cases and 2.9% of deaths, with the southern region being the most affected with 56.4% of cases and 75.0% of deaths. COVID-19 mortality was positively correlated with medical variables (national obesity rate, diabetes prevalence, cancer incidence, and cardiovascular disease mortality rate), socioeconomic characteristics (international tourism, per capita health expenditure, human development index, HDI, and years of schooling), and health system variables (nurse density, number of COVID-19 tests per capita), but negatively correlated with the population under 15 years of age and the malaria index. Interpretation: Our study suggests that higher economic status fits with high COVID-19 mortality in SSA. In this regard, it represents primarily a disease of modern and wealthy societies, and can therefore be considered as an exception among infectious diseases that historically affected more severely underserved populations living in low- and middle-income countries. However, it should be made clear that observed correlations do not imply inevitably causation and that additional studies are necessary to confirm our observations.

Indexed as

CountriesCOVID-19MortalityRisk factorsSSA, Sub-Saharan AfricaSub-Saharan Africa

Identifiers

PMID36594042
PMCPMC9797222
OpenAlexW4313219813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.